Company intelligence / Profile preview
Shogun Maitake Canada
London, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Shogun Maitake provides organic Black Maitake mushrooms grown using a proprietary method, with research—including collaborations with the University of Windsor—showing promising anti-cancer properties via induction of cell death and immune modulation; commercial supplements for cancer care adjunct and general wellness are available, but clinical trials for pharmaceutical use are ongoing[2][4].
- Therapeutic areas
- OncologyOtherImmunology
- Modalities
- BiologicDietary supplementExtract (Odaira Black Maitake Extract)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Windsor (major academic research collaboration on cancer application)[2][4]
Beyond the preview
Go deeper on Shogun Maitake Canada.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shogun Maitake Canada.